Company news

No scientist wants to wait to start an experiment. ExpressCells gets it–we were founded by scientists.

August 1st, 2022 | Company news

That’s why we developed the patented FAST-HDR gene-editing system. Want a single knock-in? In many cases, we can send you a cell pool in about 60 days. Give us a little more time and we can deliver a clonal selection and/or a cell with multiple knock-ins. We also do knock-outs and point mutations. Now you […]

How good is the ExpressCells team? So good that CIC is featuring Shamim Naghdi PhD, our amazing Scientific Director, in their new ad campaign!

June 29th, 2022 | Company news

Shamim Naghdi, Scientific Director at ExpressCells, shares her story in CIC’s latest campaign.   Learn More About CIC      

ExpressCells was delighted to be Princeton Entrepreneurs’ Network’s grand prize recipient at their recent Reunions 2022 Pitch Competition – so much so that co-founder Matt Handel even showcased his exquisite fashion sense with his Princeton Class of 1987 reunion blazer!

June 7th, 2022 | Company news

Join the ExpressCells team! We’re looking for a Senior Genetic Engineering Scientist #opportunity #geneediting

March 8th, 2022 | Company news

This is your chance to show your support for ExpressCells. We are one of 16 companies in the 2022 PHL INNO Madness Bracket.

March 2nd, 2022 | Company news

 We’re a #4 seed, but want to show we can win it all. Vote for ExpressCells in round one of the tournament! Voting ends at 11:59pm on March 7th

ExpressCells congratulates our Co-Founder, Oscar Perez Leal and his colleagues for the first publication featuring ExpressCells’ FAST-HDR gene editing system. Learn more about how FAST-HDR can help your cell-based research at xpresscells.com.

January 4th, 2022 | Company news

“We believe the FAST-HDR system is a versatile methodology for developing endogenous tagging with CRISPR according to the needs of the researcher, as it works on any cell line, facilitates multiplexing, and allows the use of any protein tag.” Download Full Press Release Dedicated to Making Your Research Better ExpressCells has 13 catalog cell lines […]

ExpressCells and Funakoshi Establish Japanese Distribution Agreement. Partnership will Introduce ExpressCells’ Genetically-Edited Cell Lines to Japan

December 20th, 2021 | Company news

ExpressCells, Inc., and Funakoshi Co., Ltd., a leading Japanese distributor of scientific products, announced today that the companies have entered into a strategic partnership where Funakoshi will distribute ExpressCells’ products in Japan. “We are honored that Funakoshi, a highly-respected company with a long history of extending the frontiers in life science, will distribute our catalog […]

Improve Your Autophagy Research with Three New Catalog Cell Lines

July 6th, 2021 | Company news

Check out the first ExpressCells catalog items based in U-2 OS cells Now you can conduct better and faster autophagy experiments using one of our three new reporter cell lines. In each one, we’ve tagged one or two proteins commonly studied in autophagy: EXP-019 SEQUESTOSOME-1/p62 tagged with mRuby3 in U-2 OS Cells EXP-020 MAP1/LC3B tagged […]

Join us June 9 at 3pm when we will be presenting as an Innovator’s Pitch Challenge finalist at the June RESI Conference

June 3rd, 2021 | Company news

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. We hope to see you at this digital 3-day conference!

ExpressCells in the News – CEO, Matthew Handel, was part of a panel discussion last week discussing why Philadelphia is a great place to be for gene and cell therapy companies.

May 20th, 2021 | Company news

Watch the Video   #philadelphia #phillytechweek

Pin It on Pinterest